D. Thompson

发表

The structures of crystalline complexes of human serum amyloid P component with its carbohydrate ligand, the cyclic pyruvate acetal of galactose.

S. Wood, M. Pepys, I. Tickle, 2002, Journal of molecular biology.

Therapeutic Inhibition of C-Reactive Protein-Novel Drugs, Novel Mechanisms

S. Ley, S. Wood, M. Pepys, 2003 .

The physiological structure of human C-reactive protein and its complex with phosphocholine.

S. Wood, M. Pepys, S P Wood, 1999, Structure.

Reactions of metals with vitamins. I. Crystal and molecular structure of thiaminium tetrachlorocadmate monohydrate.

K. Franklin, M. F. Richardson, D. Thompson, 1975, Journal of the American Chemical Society.

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis

J. Kemp, L. Lovat, T. Hoffmann, 2002, Nature.

Site-Directed Mutagenesis and X-ray Crystallography of the PQQ-Containing Quinoprotein Methanol Dehydrogenase and Its Electron Acceptor, Cytochrome cL†,‡

J. Cooper, C. Anthony, P. Goodwin, 2001 .

Site-directed mutagenesis and X-ray crystallography of the PQQ-containing quinoprotein methanol dehydrogenase and its electron acceptor, cytochrome c(L).

J. Cooper, C. Anthony, P. Goodwin, 2001, Biochemistry.

Structural studies of substrate and product complexes of 5-aminolaevulinic acid dehydratase from humans, Escherichia coli and the hyperthermophile Pyrobaculum calidifontis.

J. Cooper, Jingxu Guo, A. Coker, 2017, Acta crystallographica. Section D, Structural biology.

Amyloid and amyloidosis

D. Booth, S. Wood, M. Pepys, 1998 .